Les Turner ALS Center
Approved Treatments for ALS
Your quality of life can often be improved by various treatments and interventions. We at the Foundation realize that managing symptoms is often a full-time responsibility for the patient and their caregivers. Connecting with an ALS Care Team such as the Lois Insolia ALS Clinic at the Les Turner ALS Center at Northwestern Medicine helps people living with ALS and their families coordinate care in the best way possible. Care provided by experts in ALS multidisciplinary centers has been shown to prolong survival (Miller, et. al., 2009).
FDA Approved Treatments
Although there is no existing cure for ALS, the Les Turner ALS Foundation continues to advocate for advances in ALS research and support services, as it has for over 40 years. Listed below are FDA-approved treatments. Decisions regarding medication should be made in consultation with your neuromuscular specialist and should be part of a comprehensive treatment approach.
In May, 2017, the FDA approved the first ALS treatment in 22 years – Radicava™, an infusion treatment from MT Pharma America, also known as edaravone. According to the FDA, the pivotal clinical trial for Radicava in Japan showed a 33 percent slowing of loss of function in participants as rated on the ALS Functional Rating Scale. To learn more about Radicava™ talk with your physician.
Rilutek, also known as riluzole, was the first FDA-approved medication for the treatment of ALS, approved in 1995. It has been proven to modestly increase lifespan. To learn more about Rilutek© talk with your physician.
Nuedexta was approved by the FDA in 2011 to treat pseudobulbar affect, a symptom that can occur in ALS/MND and other neurological conditions, which is characterized by inappropriate, uncontrollable laughing and crying. To learn more about Nuedexta talk with your physician.